Cardiac Troponin T Elevation Predicts Mortality in Hospitalized COVID-19 Patients
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Objective
To evaluate if cardiac troponin values predict poor outcomes in COVID-19 patients across the range of patients of different sex and age.
Methods
We examined high-sensitivity cardiac troponin T (hs-cTnT) levels in 1,050 severely ill hospitalized COVID-19 patients who had hs-cTnT data available and participated in the Expanded Access Program for convalescent plasma study during the first wave (April-August 2020) of the COVID-19 pandemic.
Results
We observed a continuous relationship between hs-cTnT levels and mortality in hospitalized males and females with COVID-19. This finding was present regardless of sex or age.
Conclusion
These data indicate the prognostic ability of hs-cTnT to predict mortality in hospitalized COVID-19 patients across all relevant patient groups.
Clinical Trials registration number
NCT04338360
Clinical Perspective
-
This study evaluated the prognostic value of elevated hs-cTnT in patients hospitalized with COVID-19 who received convalescent plasma.
-
There was a continuous relationship between elevated hs-cTnT values and mortality in both males and females hospitalized for COVID-19.
-
The magnitude of the prognostic value of elevated hs-cTnT varied by sex and age, suggesting that these covariates are important to consider in this population.
